Investigating Biological Aging Measures, Neurocognitive Performance, and Depressive Symptoms: Moderating Effects of HIV and Childhood Maltreatment
- 1University of Cape Town
Abstract
Introduction: Neurocognitive impairment and depression remain common among people with HIV (PWH), and childhood maltreatment (CM) may further increase vulnerability. In this cohort, we previously reported that PWH exhibited shorter absolute telomere length, lower MRI-based brain-predicted age difference, and greater epigenetic age acceleration (AA) compared to controls, with limited associations with CM severity. Building on this, the present study examines whether these markers are linked to neurocognitive performance and depressive symptoms, and whether HIV status or CM severity moderates such associations. Methods: In this study of 238 women (122 PWH), biological aging was assessed using absolute telomere length, mitochondrial DNA copy number, MRI-based brain-predicted age difference, and DNA methylation AA measures, including Horvath, Hannum, PhenoAge, Horvath intrinsic epigenetic, and Hannum intrinsic epigenetic and extrinsic epigenetic AA. Neurocognitive performance was measured using a standardised assessment battery and global deficit scores (GDS) were derived. Depressive symptoms were assessed with the Centre for Epidemiologic Studies - Depression Scale. Linear regression models examined associations with GDS and depressive symptoms, with interaction models evaluating moderation by HIV status and CM severity. Results: Biological aging markers were not associated with either neurocognitive performance or depressive symptoms. Though HIV infection in combination with higher mitochondrial DNA copy number and extrinsic epigenetic AA was nominally associated with higher GDS (p = 0.012 and p = 0.047, respectively), these associations did not survive correction for multiple testing. Neither HIV nor CM moderated the association between biological aging markers and depression scores. Conclusions: Despite accelerated biological aging being evident in PWH, we found limited evidence of association with neurocognitive performance or depressive symptoms, underscoring their multifactorial nature. Larger longitudinal studies are needed to determine whether these markers predict neurocognitive and psychiatric trajectories.
Related
- Investigating which type of maltreatment has the largest impact on health: The challenge of measurement error
- Differential pathways from childhood maltreatment types to non-suicidal self-injury in adolescents with depressive disorders: a serial mediation model
- Biological aging markers in South African women with HIV and variable exposure to childhood maltreatment
- Sport-related neurocognitive performance and repetitive head-impact exposure in elite Muay Thai athletes: a matched athletic-control study.
- Neurocognitive training with visual perturbation improves dual-task hop performance in male athletes after anterior cruciate ligament reconstruction: a randomized controlled trial
BibTeX
@misc{maloka2026investigating,
title = {{Investigating Biological Aging Measures, Neurocognitive Performance, and Depressive Symptoms: Moderating Effects of HIV and Childhood Maltreatment}},
author = {K. M. S. Maloka and G. Spies and S. du Plessis and S. M. J. Hemmings and S. Letendre and S. Seedat and J. S. Womersley},
howpublished = {medRxiv},
year = {2026},
month = nov,
doi = {10.64898/2026.11.08.26367522},
url = {https://www.medrxiv.org/content/10.64898/2026.11.08.26367522v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - Investigating Biological Aging Measures, Neurocognitive Performance, and Depressive Symptoms: Moderating Effects of HIV and Childhood Maltreatment
AU - K. M. S. Maloka
AU - G. Spies
AU - S. du Plessis
AU - S. M. J. Hemmings
AU - S. Letendre
AU - S. Seedat
AU - J. S. Womersley
PY - 2026
DA - 2026/11/08
PB - medRxiv
DO - 10.64898/2026.11.08.26367522
UR - https://www.medrxiv.org/content/10.64898/2026.11.08.26367522v1
AB - Introduction: Neurocognitive impairment and depression remain common among people with HIV (PWH), and childhood maltreatment (CM) may further increase vulnerability. In this cohort, we previously reported that PWH exhibited shorter absolute telomere length, lower MRI-based brain-predicted age difference, and greater epigenetic age acceleration (AA) compared to controls, with limited associations with CM severity. Building on this, the present study examines whether these markers are linked to neurocognitive performance and depressive symptoms, and whether HIV status or CM severity moderates such associations. Methods: In this study of 238 women (122 PWH), biological aging was assessed using absolute telomere length, mitochondrial DNA copy number, MRI-based brain-predicted age difference, and DNA methylation AA measures, including Horvath, Hannum, PhenoAge, Horvath intrinsic epigenetic, and Hannum intrinsic epigenetic and extrinsic epigenetic AA. Neurocognitive performance was measured using a standardised assessment battery and global deficit scores (GDS) were derived. Depressive symptoms were assessed with the Centre for Epidemiologic Studies - Depression Scale. Linear regression models examined associations with GDS and depressive symptoms, with interaction models evaluating moderation by HIV status and CM severity. Results: Biological aging markers were not associated with either neurocognitive performance or depressive symptoms. Though HIV infection in combination with higher mitochondrial DNA copy number and extrinsic epigenetic AA was nominally associated with higher GDS (p = 0.012 and p = 0.047, respectively), these associations did not survive correction for multiple testing. Neither HIV nor CM moderated the association between biological aging markers and depression scores. Conclusions: Despite accelerated biological aging being evident in PWH, we found limited evidence of association with neurocognitive performance or depressive symptoms, underscoring their multifactorial nature. Larger longitudinal studies are needed to determine whether these markers predict neurocognitive and psychiatric trajectories.
ER -